Salem Radio Network News Thursday, May 19, 2022

Health

Abbott posts $2.3 billion in quarterly COVID test sales

(Reuters) – Abbott Laboratories reported $2.3 billion in COVID-19 test sales for the fourth quarter, majority of which were rapid test kits, tracking a sharp surge in cases led by the Omicron variant.

The company’s net earnings fell to $1.11 per share in the fourth quarter ended Dec. 31 from $1.20 per share a year earlier.

(Reporting by Leroy Leo; Editing by Maju Samuel)

Previous
Next

Editorial Cartoons

View More »

Michael Ramirez
Sun, May 15, 2022

X CLOSE